The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Jan. 30, 2009
Applicants:

Yusuke Tanigawara, Tokyo, JP;

Mitsuhiro Watanabe, Tokyo, JP;

Eri Arita, Tokyo, JP;

Akito Nishimuta, Tokyo, JP;

Yasuko Yamayoshi, Tokyo, JP;

Takeshi Matsuzaki, Tokyo, JP;

Shinji Sugimoto, Tokyo, JP;

Inventors:

Yusuke Tanigawara, Tokyo, JP;

Mitsuhiro Watanabe, Tokyo, JP;

Eri Arita, Tokyo, JP;

Akito Nishimuta, Tokyo, JP;

Yasuko Yamayoshi, Tokyo, JP;

Takeshi Matsuzaki, Tokyo, JP;

Shinji Sugimoto, Tokyo, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/53 (2006.01); A61K 31/4745 (2006.01); A61K 45/06 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4745 (2013.01); A61K 45/06 (2013.01); G01N 33/5011 (2013.01); G01N 33/6812 (2013.01); G01N 2800/52 (2013.01); Y10S 436/813 (2013.01);
Abstract

Provided are a marker for determining sensitivity to an anticancer agent capable of distinguishing a therapeutic response of an individual patient and a novel means for a cancer therapy using the marker. The marker for determining sensitivity to an anticancer agent contains a substance in a metabolic pathway in which L-phenylalanine and/or N,N-dimethyl glycine are/is involved.


Find Patent Forward Citations

Loading…